Novavax (NVAX) Other Accumulated Expenses (2013 - 2026)
Novavax's Other Accumulated Expenses came in at $135.53 million for Q2 2026, up 2.3% from $132.53 million a year earlier and up 2.3% from the prior quarter.
Powered by 
Analysis
Novavax (NVAX) Other Accumulated Expenses (2013 - 2026) Analysis & Trends
At the end of FY2025, Novavax's Other Accumulated Expenses was $137.78 million, down 37.3% from FY2024.
- Other Accumulated Expenses has declined in each of the last three years, though with a five-year compound annual growth rate of 73.1% (FY2020 to FY2025).
- Going back by year, Other Accumulated Expenses was $219.6 million in FY2024 (-74.5%), $861.41 million in FY2023 (-7.4%), $930.06 million in FY2022 and $36.06 million in FY2021 (+307.0%).
- The five-year range for quarterly Other Accumulated Expenses is $3.64 million (Q3 2021) to $930.06 million (Q4 2022).
- Year-over-year, Other Accumulated Expenses increased in 1 of the last eight quarters, with an average decline of 40.2%.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in Q3 2023 (growth of 437.0%), and the weakest in Q4 2024 (a decline of 74.5%).
- Business Quant data shows NVAX's Other Accumulated Expenses at $132.45 million (Q1 2026), $137.78 million (Q4 2025) and $138.33 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Novavax | 1.72 Bn | -1.28 Bn | 42.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 135.53 Mn |
| Mar 31, 2026 | 132.45 Mn |
| Dec 31, 2025 | 137.78 Mn |
| Sep 30, 2025 | 138.33 Mn |
| Jun 30, 2025 | 132.53 Mn |
| Mar 31, 2025 | 142.03 Mn |
| Dec 31, 2024 | 219.60 Mn |
| Sep 30, 2024 | 281.72 Mn |
| Jun 30, 2024 | 242.81 Mn |
| Mar 31, 2024 | 242.10 Mn |
| Dec 31, 2023 | 861.41 Mn |
| Sep 30, 2023 | 861.96 Mn |
| Jun 30, 2023 | 749.19 Mn |
| Mar 31, 2023 | 858.38 Mn |
| Dec 31, 2022 | 930.06 Mn |
| Sep 30, 2022 | 160.50 Mn |
| Jun 30, 2022 | 34.16 Mn |
| Mar 31, 2022 | 31.27 Mn |
| Dec 31, 2021 | 36.06 Mn |
| Sep 30, 2021 | 3.64 Mn |
API Access
Novavax Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();